- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Exo Launches Point-of-Care Ultrasound Package Exo Works Connect
The package of point-of-care ultrasound (POCUS) applications can reportedly facilitate rapid implementation of POCUS into imaging workflows.
For hospitals, clinics and other facilities that have struggled to adopt the use of point-of-care ultrasound (POCUS), Exo has unveiled a package of POCUS applications with Exo Works Connect.
In addition to facilitating real-time collaboration between clinicians, Exo Works Connect streamlines documentation for ultrasound exams, according to Exo. The company notes that storage of images with Exo Works Connect can be compatible with a facility’s existing Picture Archiving Communication Systems (PACS), a vendor-neutral archive or through an Exo Works cloud system. Exo emphasizes that Exo Works Connect can be securely and quickly integrated into a facility’s IT infrastructure.
Image storage with the newly launched Exo Works Connect can be compatible with a facility’s existing Picture Archiving Communication Systems (PACS), a vendor-neutral archive or through an Exo Works cloud system, according to Exo, the developer of Exo Works Connect. Exo emphasizes that Exo Works Connect can be securely and quickly integrated into a facility’s IT infrastructure. (Image courtesy of Exo.)
“Exo Works Connect has been designed for a low touch installation, enabling organizations to deploy a secure and compliant POCUS program in days, not months. As a result, providers can focus their time on improving quality, maintaining compliance, and enhancing ultrasound proficiency,” noted Sandeep Akkaraju, the co-founder and CEO of Exo.
Exo added that Exo Works Connect also provides a feature that tracks user proficiency, potentially making it a good complementary system for ultrasound education programs.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
